Verwendung von Telomerasehemmern zur Behandlung von Myeloproliferativen Erkrankungen und Myeloproliferativen Neoplasmen

Details

Veröffentlichungs-Nr.

EP4751723

Anmeldetag

15. November 2013

Veröffentlichung

3. Juni 2026

Rechtsraum

EP

Abstract

Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myelodysplastic syndrome. Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myelodysplastic syndrome.

Anmelder

Firma

Geron Corporation

Land

🇺🇸 USA